LM11A-31-BHS

· PharmatrophiX Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LM11A-31-BHS, covering 2020-09-04 to 2020-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of LM11A-31-BHS in Mild-moderate AD Patients [Phase 1, Phase 2]